RZLT

RZLT

USD

Rezolute Inc. Common Stock (NV)

$8.900-0.020 (-0.224%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$8.920

High

$9.000

Low

$8.820

Volume

1.64M

Company Fundamentals

Market Cap

808.4M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.24M

Exchange

NCM

Currency

USD

52-Week Range

Low $2.215Current $8.900High $10.04

Related News

Analyst Upgrades

Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17

Citizens analyst Jason N. Butler maintains Rezolute with a Market Outperform and raises the price target from $9 to $17.

View more
Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17
GlobeNewswire

Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

View more
Rezolute to Participate in Upcoming Investor Conferences
GlobeNewswire

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

View more
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)